Tianjin Chase Sun Pharmaceutical Co.,Ltd
Shenzhen Stock Exchange 300026.SZ
Tianjin Chase Sun Pharmaceutical Co.,Ltd Cash and Short-Term Investments for the year ending December 31, 2023: USD 221.65 M
-
Tianjin Chase Sun Pharmaceutical Co.,Ltd Cash and Short-Term Investments for the year ending December 31, 2022 was USD 174.79 M, a -15.60% change year over year.
-
Tianjin Chase Sun Pharmaceutical Co.,Ltd Cash and Short-Term Investments for the year ending December 31, 2021 was USD 207.11 M, a 20.08% change year over year.
-
Tianjin Chase Sun Pharmaceutical Co.,Ltd Cash and Short-Term Investments for the year ending December 31, 2020 was USD 172.47 M, a 21.57% change year over year.
-
Tianjin Chase Sun Pharmaceutical Co.,Ltd Cash and Short-Term Investments for the year ending December 31, 2019 was USD 141.87 M, a -19.26% change year over year.
| Date | Cash and Short-Term Investments | Receivables | Inventory | Goodwill |
|---|
| CEO | Ms. Dan Zheng |
| IPO Date | Oct. 30, 2009 |
| Location | China |
| Headquarters | No. 20, Quanfa Road |
| Employees | 5,910 |
| Sector | Health Care |
| Industries | |
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email